BMP4 and juvenile myelomonocytic leukemia: Elevated BMP4 methylation correlated with patient age and fetal hemoglobin (HbF) levels, which are both established predictors of reduced survival, highlighting BMP4 as a biomarker for clinical risk in JMML.